MLchartDataset catalogue

Proxinium

Term · Oncology and biomedicine · MLC-T-ONC-007029

A substance being studied in the treatment of certain types of head and neck cancer. Proxinium is made by linking a monoclonal antibody fragment to a toxic protein that may kill cancer cells. It binds to EpCAM (a protein on the surface of epithelial cells and some types of cancer cells). Also called anti-EpCAM-Pseudomonas-exotoxin fusion protein and VB4-845.

Table 1. Record
IdentifierMLC-T-ONC-007029
FieldOncology and biomedicine
Synonymsanti-EpCAM-Pseudomonas-exotoxin fusion protein; VB4-845
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-007029",
  "term": "Proxinium",
  "field": "Oncology and biomedicine",
  "definition": "A substance being studied in the treatment of certain types of head and neck cancer. Proxinium is made by linking a monoclonal antibody fragment to a toxic protein that may kill cancer cells. It binds to EpCAM (a protein on the surface of epithelial cells and some types of cancer cells). Also called anti-EpCAM-Pseudomonas-exotoxin fusion protein and VB4-845.",
  "synonyms": [
    "anti-EpCAM-Pseudomonas-exotoxin fusion protein",
    "VB4-845"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/proxinium/"
}

Record 13,788 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.